Polymer Neurovascular Stent Retrievers Sales

Polymer Neurovascular Stent Retrievers Sales Market Outlook

The global polymer neurovascular stent retrievers market is poised for significant growth, estimated to reach approximately USD 1.5 billion by 2035, with a compound annual growth rate (CAGR) of around 9.2% during the forecast period of 2025 to 2035. This growth can primarily be attributed to the increasing prevalence of neurological disorders, particularly stroke, which has spurred demand for effective endovascular treatments. Furthermore, advancements in stent retriever technology, including enhanced biocompatibility and improved delivery systems, have bolstered market expansion as healthcare providers seek more efficient solutions for vascular interventions. The rising geriatric population across the globe, which is more susceptible to vascular diseases, further propels market demand. Additionally, the growing awareness regarding stroke management and the push for minimally invasive procedures are also critical factors fostering market growth.

Growth Factor of the Market

One of the primary growth factors driving the polymer neurovascular stent retrievers market is the rising incidence of cerebrovascular diseases, particularly among aging populations. The increasing incidence of ischemic strokes, which often require the use of stent retrievers for effective thrombus removal, has significantly escalated the demand for these medical devices. Moreover, advancements in medical technology have led to the development of innovative stent retrieval systems that offer superior efficacy and safety profiles. As hospitals and healthcare facilities increasingly adopt these advanced technologies, the demand for polymer neurovascular stent retrievers continues to rise. Additionally, favorable reimbursement policies and government initiatives aimed at improving stroke care have created a conducive environment for market growth. The focus on enhancing patient outcomes and reducing hospitalization times has further encouraged the use of stent retrievers in various clinical settings.

Key Highlights of the Market

• The polymer neurovascular stent retrievers market is projected to grow significantly, driven by advancements in medical technology and increasing cerebrovascular diseases.
• North America holds a dominant market share due to advanced healthcare infrastructure and high prevalence of neurological disorders.
• The balloon-expandable stent retrievers segment is expected to witness robust growth owing to their superior flexibility and adaptability.
• Online pharmacies are emerging as a vital distribution channel, facilitating wider access to these medical devices.
• Innovations in biocompatible materials are enhancing the safety and effectiveness of neurovascular stent retrievers, contributing to market expansion.

By Product Type

Balloon-expandable Stent Retrievers:

Balloon-expandable stent retrievers are characterized by their ability to expand using a balloon mechanism, which provides optimal radial force and adherence to the vessel wall. This type of stent retriever is highly effective in treating acute ischemic stroke by allowing for better thrombus engagement and retrieval. The growing preference for minimally invasive procedures among healthcare providers is bolstering the adoption of balloon-expandable stent retrievers. Additionally, advancements such as customizable balloon sizes and improved delivery systems are further enhancing their appeal in clinical applications. Moreover, ongoing research indicates that these stent retrievers may improve patient outcomes significantly, contributing to their increasing market presence.

Self-expanding Stent Retrievers:

Self-expanding stent retrievers utilize a unique design that allows them to expand automatically upon deployment, which reduces the risk of vessel trauma during the retrieval process. This characteristic makes them particularly advantageous in challenging anatomical environments. Self-expanding stent retrievers have gained traction due to their ability to adapt to various vessel diameters and their effectiveness in capturing thrombus. The increasing incidence of complex vascular cases, along with the growing adoption of these devices in clinical settings, is driving the growth of the self-expanding stent retrievers segment. Furthermore, manufacturers are innovating new designs that enhance retrieval efficiency and reduce complications, thus augmenting market demand.

Coil-assisted Stent Retrievers:

Coil-assisted stent retrievers represent a hybrid approach that combines the benefits of traditional stent retrievers with the complementary action of coils. This approach enhances the ability to capture and remove thrombus effectively, particularly in cases where conventional methods may fall short. The demand for coil-assisted stent retrievers is growing as they offer improved stability and reduced risk of dislodging thrombus during the retrieval process. Additionally, their unique design allows for better navigation through tortuous vasculature, making them suitable for a broader range of clinical scenarios. Continuous advancements aimed at optimizing their design and functionality are expected to drive further adoption in hospitals and surgical centers.

Braided Stent Retrievers:

Braided stent retrievers are crafted using multiple strands of metal filaments, resulting in a flexible and resilient design that enables effective thrombus retrieval. This type of stent retriever is highly regarded for its ability to conform to the vascular anatomy while maintaining structural integrity. The increasing preference for braided stent retrievers can be attributed to their enhanced maneuverability and ability to navigate through complex vascular networks. Additionally, with ongoing advancements in manufacturing techniques, the performance characteristics of braided stent retrievers are continually improving, leading to increased trust and reliance among healthcare professionals. As the market evolves, the segment is expected to gain a larger share due to its distinctive attributes.

Mesh Stent Retrievers:

Mesh stent retrievers are designed with a lattice-like mesh structure that allows for superior visibility and flexibility during the retrieval process. This innovative design facilitates the capture of thrombus while minimizing the risk of damaging the vessel walls. Mesh stent retrievers are gaining popularity due to their effectiveness in complex cases where other devices may encounter limitations. Their ability to provide enhanced feedback during procedures and limit the risk of complications is appealing to surgeons. As the demand for effective stroke interventions continues to rise, the mesh stent retrievers segment is anticipated to grow, driven by ongoing product improvements and increased awareness of their benefits in clinical practice.

By Application

Hospitals:

Hospitals are the primary application segment for polymer neurovascular stent retrievers, accounting for a significant share of the market. The high incidence of cerebrovascular emergencies necessitates immediate access to advanced stent retrieval technologies in hospital settings. Hospitals are equipped with specialized stroke units, ensuring that patients receive timely interventions, which significantly enhances recovery outcomes. Furthermore, hospitals typically have access to the latest technologies and resources, allowing for better implementation of innovative stent retrieval methods. As hospitals continue to invest in cutting-edge medical equipment and improve stroke management protocols, the demand for stent retrievers in this setting is expected to grow substantially.

Ambulatory Surgical Centers:

Ambulatory surgical centers (ASCs) are increasingly being recognized for their role in providing specialized interventional procedures, including neurovascular treatments. The shift towards outpatient care is driving the growth of stent retrievers in ASCs, as these facilities offer a cost-effective alternative for patients requiring less invasive procedures. The ability to perform quick interventions in a streamlined setting appeals to both patients and healthcare providers. Moreover, advancements in technology enable ASCs to adopt modern neurovascular devices, including polymer stent retrievers, which further enhances their service offerings. As patient preferences shift towards outpatient procedures, ASCs are expected to see significant growth in the usage of neurovascular stent retrievers.

Specialty Clinics:

Specialty clinics that focus on neurovascular care are becoming vital in the management of cerebrovascular diseases. These specialized facilities often employ the latest technologies in stent retrieval procedures, catering to patients with specific needs. The increasing prevalence of neurological conditions has led to the establishment of dedicated clinics that provide comprehensive care and intervention services. The adoption of polymer neurovascular stent retrievers in specialty clinics is facilitated by the demand for targeted treatment options that can effectively address complex vascular cases. As awareness and demand for specialized care grow, these clinics are likely to expand their use of stent retrieval technologies.

Others:

The "Others" application segment includes various healthcare settings such as research institutions and rehabilitation centers that may utilize polymer neurovascular stent retrievers for different purposes. Research institutions often play a critical role in advancing medical technologies and may utilize stent retrievers for clinical trials and studies aimed at improving stroke interventions. Rehabilitation centers may also benefit from the use of these devices in training healthcare professionals and providing advanced therapeutic techniques. While this segment may hold a smaller market share compared to hospitals and ASCs, it is still essential in fostering innovation and expanding the applications of stent retrieval technologies.

By Distribution Channel

Hospital Pharmacies:

Hospital pharmacies serve as a key distribution channel for polymer neurovascular stent retrievers, primarily because they are closely integrated with the healthcare facilities that utilize these devices. The convenience of having stent retrievers readily available within hospitals facilitates quick response times during critical interventions. Hospital pharmacies typically stock a range of advanced medical devices, including stent retrievers, ensuring that healthcare professionals have immediate access to the necessary tools for acute stroke management. The ongoing partnerships between hospitals and medical device manufacturers are expected to strengthen this distribution channel, further enhancing the availability of polymer neurovascular stent retrievers.

Retail Pharmacies:

Retail pharmacies represent a growing distribution channel for polymer neurovascular stent retrievers, especially in regions where access to hospital-based services may be limited. As healthcare systems continue to evolve, retail pharmacies are increasingly offering a wider range of medical devices and products. This segment is particularly relevant for patients requiring follow-up care or those who may need access to stent retrieval systems for outpatient procedures. The integration of retail pharmacies into the healthcare landscape not only enhances patient access to necessary medical devices but also promotes awareness of the importance of stroke management technologies among the general public. The growth of retail pharmacies as a distribution channel is expected to continue as healthcare providers seek to improve patient access to critical interventions.

Online Pharmacies:

Online pharmacies are emerging as an important distribution channel for polymer neurovascular stent retrievers, driven by the growing trend of e-commerce in the healthcare sector. The convenience and accessibility of online purchasing are appealing to both healthcare providers and patients, particularly in regions where traditional distribution channels may be less accessible. Additionally, online pharmacies often offer competitive pricing and a wider selection of medical devices, which can enhance the purchasing experience. As the regulatory landscape continues to evolve, and with a growing focus on telemedicine, the significance of online pharmacies in the distribution of stent retrievers is likely to expand, complementing traditional channels.

Others:

The "Others" distribution channel category encompasses various non-traditional outlets such as specialty care providers and direct sales from manufacturers. These channels may include direct purchases from manufacturers for unique or specialized products that are not available through conventional pharmacies. The use of direct sales can facilitate a more tailored approach to procurement, allowing healthcare providers to obtain specific stent retrieval devices that meet their individual needs. As the market continues to expand, new distribution strategies and partnerships are likely to emerge, further diversifying the ways in which polymer neurovascular stent retrievers reach healthcare practitioners.

By Material Type

Nitinol:

Nitinol, an alloy of nickel and titanium, is widely used in the manufacturing of polymer neurovascular stent retrievers due to its unique shape memory properties and biocompatibility. The flexibility and resilience of nitinol allow for effective navigation through the vascular system while minimizing the risk of vessel damage during procedures. This material's ability to return to its predetermined shape after deformation enhances the functionality of stent retrievers, making them more effective in capturing thrombus. As a result, the demand for nitinol-based stent retrievers continues to grow, propelled by ongoing advancements in manufacturing techniques aimed at improving device performance and patient outcomes.

Stainless Steel:

Stainless steel is another commonly used material for polymer neurovascular stent retrievers, owing to its strength, durability, and resistance to corrosion. The inert nature of stainless steel makes it an excellent choice for medical devices, as it reduces the risk of adverse reactions when in contact with body tissues. Stainless steel stent retrievers are known for their robustness and reliability, which are critical factors in emergency medical situations. The established history of stainless steel in surgical applications further enhances its appeal among healthcare practitioners, ensuring continued demand for stainless steel-based neurovascular stent retrievers in the market.

Platinum:

Platinum is often utilized in specialized stent retrievers due to its exceptional radiopacity and biocompatibility, allowing for better visibility during imaging procedures. The high radiopacity of platinum aids healthcare providers in accurately locating and navigating stent retrievers within the vascular system. This characteristic is particularly advantageous during complex procedures where precision is crucial. Additionally, platinum's resistance to corrosion and wear ensures that stent retrievers maintain their integrity over time. As the market evolves and the demand for precision in medical interventions grows, the use of platinum in stent retrievers is expected to expand, driven by innovations aimed at enhancing device visibility and performance.

Cobalt-Chromium:

Cobalt-chromium alloys are emerging as a viable material choice for polymer neurovascular stent retrievers, offering a combination of enhanced strength and biocompatibility. The unique properties of cobalt-chromium allow for the manufacture of slimmer stent profiles without compromising structural integrity. This advantage is particularly beneficial in navigating tortuous vessels and improving patient comfort. The increasing interest in cobalt-chromium stent retrievers is driven by advancements in material science, leading to improved manufacturing techniques that enhance device efficacy. As healthcare providers seek more effective solutions for stroke interventions, cobalt-chromium stent retrievers are likely to gain traction in the market.

Others:

The "Others" material type category includes various alternative materials that may be utilized in the production of polymer neurovascular stent retrievers. These may encompass emerging materials with unique properties that could enhance the performance and safety of stent retrieval technologies. Research and development efforts are ongoing, exploring the potential of novel materials that could provide additional benefits, such as improved flexibility, reduced thrombogenicity, or enhanced visibility during procedures. As the field of medical device manufacturing advances, the exploration of alternative materials will likely contribute to the innovation and diversification of polymer neurovascular stent retrievers.

By Region

The North American region commands a significant share of the polymer neurovascular stent retrievers market, driven by the high prevalence of cerebrovascular diseases and an advanced healthcare infrastructure. The region's hospitals and healthcare facilities increasingly adopt innovative stent retrieval technologies, which contributes to substantial market growth. The robust presence of key players in the region and continuous research efforts also play a crucial role in driving advancements in stent retriever technologies. Furthermore, the North American market is projected to grow at a CAGR of approximately 8.5% from 2025 to 2035, reflecting the increasing focus on improving stroke management and patient outcomes through advanced medical devices.

Europe also plays a critical role in the polymer neurovascular stent retrievers market, with an increasing awareness of stroke management protocols and a growing demand for minimally invasive procedures. The European market benefits from a well-established healthcare system, ensuring access to advanced medical technologies. Countries like Germany, France, and the UK are leading the charge in adopting innovative neurovascular solutions, significantly contributing to market growth. However, the European market is expected to maintain steady growth, driven by the ongoing integration of advanced stent retrievers into clinical practice and the growing emphasis on improved patient care.

Opportunities

Significant opportunities exist in the polymer neurovascular stent retrievers market, particularly in emerging economies where healthcare infrastructure is rapidly improving. As these regions develop, there is a growing demand for advanced medical technologies, including neurovascular devices. Healthcare providers in these areas are increasingly seeking effective solutions for managing cerebrovascular diseases, creating a potential market for stent retrievers that cater to their specific needs. Furthermore, the rising awareness of stroke prevention and management is likely to drive investments in healthcare facilities, leading to increased adoption of polymer neurovascular stent retrievers. Collaborations between local healthcare providers and international manufacturers can further facilitate market entry and expansion in these regions.

Another promising opportunity lies in the ongoing research and development efforts aimed at enhancing the functionalities of polymer neurovascular stent retrievers. Innovations such as the integration of smart technologies, which can provide real-time feedback and monitoring during procedures, are gaining traction in the market. The increasing focus on personalized medicine and tailored treatment options presents an avenue for manufacturers to develop advanced stent retrieval systems that cater to the unique needs of individual patients. By investing in innovative solutions and addressing the evolving demands of healthcare professionals, companies can capitalize on the growing opportunities within the polymer neurovascular stent retrievers market.

Threats

Despite the positive outlook, the polymer neurovascular stent retrievers market faces several threats that could impact its growth trajectory. One of the primary threats is the potential for regulatory hurdles that can delay the introduction of new products into the market. Stringent regulatory requirements necessitate extensive testing and validation processes, which can slow down innovation and limit the availability of advanced stent retrievers. Additionally, the evolving landscape of healthcare regulations in various regions may pose challenges for manufacturers seeking to meet compliance standards, potentially hindering market expansion. Furthermore, the increasing prevalence of counterfeit medical devices can undermine the credibility of legitimate products, affecting the overall reputation of the industry.

Another significant threat is the competition from alternative treatment options for cerebrovascular diseases, including pharmacological interventions and surgical procedures that may bypass the need for stent retrievers. As healthcare providers explore various treatment modalities, the demand for stent retrievers may be influenced by the perceived effectiveness and cost-effectiveness of alternative solutions. Additionally, economic fluctuations and changes in healthcare funding can impact hospital budgets and their ability to invest in advanced medical devices, potentially posing a challenge to market growth. To mitigate these threats, manufacturers must focus on continuous innovation and establish strong collaborations with healthcare providers to demonstrate the value of their products in stroke management.

Competitor Outlook

• Medtronic plc
• Boston Scientific Corporation
• Penumbra, Inc.
• Terumo Corporation
• Stryker Corporation
• MicroVention, Inc.
• Johnson & Johnson
• Abbott Laboratories
• Asahi Intecc Co., Ltd.
• iVascular S.L.U.
• Neuravi Ltd.
• Acandis GmbH
• REVA Medical, Inc.
• Cardinal Health, Inc.
• Terumo Interventional Systems

The competitive landscape of the polymer neurovascular stent retrievers market is characterized by the presence of several key players actively engaged in developing innovative products and expanding their market reach. These companies are focused on enhancing their technological capabilities and improving patient outcomes through advanced stent retriever designs. Medtronic plc and Boston Scientific Corporation are among the leading players, leveraging their extensive research and development resources to introduce cutting-edge technologies that address the diverse needs of healthcare providers. Additionally, collaborations with hospitals and healthcare institutions are becoming increasingly common to facilitate the adoption of their products in clinical practice.

Penumbra, Inc. is another significant player in the market, known for its innovative approaches to neurovascular interventions. The company has developed a range of advanced stent retrievers that are designed to enhance the efficiency and safety of stroke procedures. Similarly, Terumo Corporation and Stryker Corporation have made substantial investments in research and development, focusing on creating products with improved navigability and effectiveness in challenging anatomical situations. These companies are also actively pursuing strategic partnerships and mergers to strengthen their market position and expand their product offerings.

Furthermore, smaller players such as MicroVention, Inc. and Neuravi Ltd. are carving out their niche in the market by specializing in unique stent retrieval technologies and personalized approaches to stroke management. These companies are leveraging their agility and innovative capabilities to compete with larger players by offering specialized products that cater to specific patient needs. As the market continues to evolve, the competitive landscape is expected to remain dynamic, with ongoing innovations and collaborations shaping the future of polymer neurovascular stent retrievers.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 Acandis GmbH
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Neuravi Ltd.
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Medtronic plc
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Penumbra, Inc.
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 iVascular S.L.U.
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Johnson & Johnson
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 MicroVention, Inc.
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 REVA Medical, Inc.
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Terumo Corporation
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Abbott Laboratories
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Stryker Corporation
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Cardinal Health, Inc.
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Asahi Intecc Co., Ltd.
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Boston Scientific Corporation
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Terumo Interventional Systems
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Polymer Neurovascular Stent Retrievers Sales Market, By Application
    • 6.1.1 Hospitals
    • 6.1.2 Ambulatory Surgical Centers
    • 6.1.3 Specialty Clinics
    • 6.1.4 Others
  • 6.2 Polymer Neurovascular Stent Retrievers Sales Market, By Product Type
    • 6.2.1 Balloon-expandable Stent Retrievers
    • 6.2.2 Self-expanding Stent Retrievers
    • 6.2.3 Coil-assisted Stent Retrievers
    • 6.2.4 Braided Stent Retrievers
    • 6.2.5 Mesh Stent Retrievers
  • 6.3 Polymer Neurovascular Stent Retrievers Sales Market, By Material Type
    • 6.3.1 Nitinol
    • 6.3.2 Stainless Steel
    • 6.3.3 Platinum
    • 6.3.4 Cobalt-Chromium
    • 6.3.5 Others
  • 6.4 Polymer Neurovascular Stent Retrievers Sales Market, By Distribution Channel
    • 6.4.1 Hospital Pharmacies
    • 6.4.2 Retail Pharmacies
    • 6.4.3 Online Pharmacies
    • 6.4.4 Others

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Middle East & Africa - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 Middle East
      • 10.5.1.2 Africa
  • 10.6 Polymer Neurovascular Stent Retrievers Sales Market by Region

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Polymer Neurovascular Stent Retrievers Sales market is categorized based on

By Product Type

• Balloon-expandable Stent Retrievers
• Self-expanding Stent Retrievers
• Coil-assisted Stent Retrievers
• Braided Stent Retrievers
• Mesh Stent Retrievers

By Application

• Hospitals
• Ambulatory Surgical Centers
• Specialty Clinics
• Others

By Distribution Channel

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• Others

By Material Type

• Nitinol
• Stainless Steel
• Platinum
• Cobalt-Chromium
• Others

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Medtronic plc
• Boston Scientific Corporation
• Penumbra, Inc.
• Terumo Corporation
• Stryker Corporation
• MicroVention, Inc.
• Johnson & Johnson
• Abbott Laboratories
• Asahi Intecc Co., Ltd.
• iVascular S.L.U.
• Neuravi Ltd.
• Acandis GmbH
• REVA Medical, Inc.
• Cardinal Health, Inc.
• Terumo Interventional Systems